In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

BacFree ts marks an important step towards more efficient and cleaner vaccine production. The method not only helps create better VLP-based vaccines but could also pave the way for cheaper and faster ...

Several drugmakers have offered to partner with the companies producing COVID-19 vaccines to boost production, but many of the vaccine makers are rejecting the help, Politico reported. Biolyse, based ...

The effort in the United States to produce and distribute a coronavirus vaccine appears to be a bright spot in the nation’s response to the pandemic. The U.S. has managed to get at least one dose to ...

In the twentieth century, the development and delivery of vaccines as part of large, systematic immunization programs helped to address many health inequities. However, safety concerns due to ...

Since COVID, there've been growing initiatives in Africa to start producing vaccines and medicines locally, thus gaining greater independence from global supply chains. But are these schemes ...

Conjugate vaccines are composed of bacterial polysaccharide antigens covalently linked to protein carriers, enabling T cell-dependent immune responses that induce high-affinity antibodies and ...